Topic: translational research


Trio of pharmas back $45M round for early fibrotic disease startup

A trio of pharmas have bought into the vision of early startup Blade Therapeutics. Pfizer Venture Investments, Novartis Institutes for Biomedical Research and Bristol-Myers Squibb all came in to the $45 million Series B round for the startup, which aims to address novel targets in fibrotic disease. It expects to get into the clinic with this financing